Product image of Maxidex (Dexamethasone) supplied by GNH India

Maxidex

Active Ingredient:
Dexamethasone
Origin:
EU

Maxidex (Dexamethasone)

Dexamethasone, the active ingredient in Maxidex, is a corticosteroid presented as an ophthalmic solution for ocular use. It reduces inflammation and pain in a variety of eye conditions, particularly after surgery or in inflammatory eye disease. Maxidex is administered directly to the eye as directed by a qualified eye‑care professional.

GNH India supplies Maxidex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Novartis Farmacéutica S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Maxidex is a corticosteroid eye drop used to manage inflammatory conditions of the eye. It acts locally to control swelling and discomfort.

  • Post‑operative ocular inflammation: reduces swelling and pain after eye surgery.
  • Anterior uveitis: controls intra‑ocular inflammation and prevents tissue damage.
  • Allergic conjunctivitis: alleviates redness, itching and swelling caused by allergic reactions.

How It Works

  • Dexamethasone binds to intracellular glucocorticoid receptors in ocular tissues, forming a complex that translocates to the nucleus and modulates gene transcription. This action suppresses the production of pro‑inflammatory cytokines, reduces leukocyte migration, and stabilises lysosomal membranes, resulting in decreased inflammation and immune response within the eye.

Side Effects

Adverse reactions may occur with ocular dexamethasone use. Patients should be monitored for both frequent and less common events.

Common Side Effects

  • Transient eye irritation or burning sensation.
  • Blurred vision.
  • Increased intra‑ocular pressure.
  • Conjunctival hyperemia.
  • Tearing or watery eyes.
  • Foreign body sensation.

Serious or Rare Side Effects

  • Secondary glaucoma.
  • Cataract formation with prolonged use.
  • Ocular infection (bacterial, fungal, or viral).
  • Delayed wound healing after surgery.
  • Severe hypersensitivity or allergic reaction.
  • Corneal ulceration.

Precautions & Warnings

Before prescribing Maxidex, clinicians should consider several safety measures.

  • Intra‑ocular pressure monitoring: check pressure before and during therapy.
  • Viral eye infections: avoid use in active herpes simplex or varicella‑zoster infections.
  • Diabetes mellitus: monitor blood glucose as steroids may affect control.
  • Cataract risk: limit duration in patients with pre‑existing lens opacity.
  • Contact lens wear: advise removal during treatment to reduce irritation.
  • Store at below 25°C: keep in original container, protect from moisture and direct sunlight.

Avoid Interactions

Dexamethasone eye drops can interact with other ocular or systemic agents.

Major Interactions (Avoid)

  • Systemic corticosteroids: may increase systemic glucocorticoid effects.
  • Topical non‑steroidal anti‑inflammatory drugs (NSAIDs): heightened risk of corneal melting.
  • Antiviral eye medications: potential reduction in antiviral efficacy.

Moderate Interactions (Monitor Closely)

  • Antifungal eye drops: monitor for reduced antifungal activity.
  • Beta‑blocker eye drops: possible additive intra‑ocular pressure effects.
  • CYP3A4 inducers (e.g., rifampin): may decrease local steroid concentration.
  • Anticholinergic eye drops: watch for delayed pupil dilation.
  • Immunosuppressants: increased risk of infection.

Frequently Asked Questions

Maxidex is an ophthalmic corticosteroid eye drop indicated for the treatment of ocular inflammation, including postoperative inflammation, anterior uveitis, and allergic conjunctivitis. It helps reduce swelling, pain, and redness in the eye.

Dexamethasone binds to glucocorticoid receptors in eye tissues, altering gene transcription to suppress inflammatory cytokines, reduce leukocyte migration, and stabilize cell membranes, thereby decreasing inflammation and immune activity locally within the eye.

The dosing regimen for Maxidex is determined by the prescribing eye‑care professional based on the specific condition, severity, and patient response. Patients should follow the exact instructions provided by their clinician.

The safety of Maxidex in pregnancy or while breastfeeding has not been definitively established. Clinicians should weigh potential benefits against risks and consider alternative therapies when appropriate.

To order Maxidex, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Maxidex (dexamethasone) is a potent corticosteroid with a rapid anti‑inflammatory effect, similar to other eye drops like prednisolone acetate. Choice of agent depends on factors such as potency, dosing frequency, patient tolerance, and specific clinical scenario.

Store Maxidex at temperatures below 25 °C, in its original container, protected from moisture and direct sunlight. Keep the bottle tightly closed and avoid freezing.

Maxidex is applied directly to the affected eye(s) as a drop, typically using the recommended number of drops per dose. Patients should wash their hands, avoid touching the tip of the bottle to the eye or any surface, and follow the prescriber’s schedule.

Serious risks include secondary glaucoma, cataract formation with prolonged use, ocular infections, delayed wound healing, and severe allergic reactions. Patients should report any sudden vision changes, eye pain, or signs of infection promptly.

Maxidex should be avoided in patients with active viral eye infections (e.g., herpes simplex keratitis), known hypersensitivity to dexamethasone or any formulation component, and in individuals where the risk of increased intra‑ocular pressure outweighs the benefit.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Dexamethasone

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT